CWM
CMPX icon

CIBC World Markets’s Compass Therapeutics CMPX Stock Holding History

CIBC World Markets’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$29.4K Sell
11,294
-11,336
-50% -$23.4K ﹤0.01% 1508
2025
Q1 		$43K Buy
+22,630
New +$60.2K ﹤0.01% 1732

Other funds holding CMPX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIBC World Markets's CMPX Position: Q2 2025 in Review

CIBC World Markets reduced its Compass Therapeutics (CMPX) stake by 50% in Q2 2025, selling an estimated $23.4K and leaving 11,294 shares worth $29.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1508.

CIBC World Markets first reported a position in CMPX in Q1 2025 and has held it in 2 quarters since. The position peaked at $43K in Q1 2025. 103 funds tracked by Wall St. Rank hold CMPX as of Q2 2025.

  • CIBC World Markets held 11,294 shares of Compass Therapeutics worth $29.4K as of Q2 2025.
  • CIBC World Markets sold 11,336 Compass Therapeutics shares in Q2 2025, an estimated $23.4K.
  • Compass Therapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1508 holding.
  • CIBC World Markets first reported a position in Compass Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • CIBC World Markets's Compass Therapeutics position peaked at $43K in Q1 2025.
  • 103 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.